The investigation of the role of proteoglycans and ADAMTS levels in fetal membranes in physiopathological process of gestational diabetes

Medical Hypotheses

Volumn 104, Issue , 2017, Pages 182-184

  Ozler, Sibel ^a   Demircan, Kadir ^b  

^a ZEKAI TAHIR BURAK WOMEN S HEALTH EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b TURGUT OZAL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMTS PROTEIN; ADAMTS9 PROTEIN; PERLECAN; PROTEOGLYCAN; ADAMTS9 PROTEIN, HUMAN;

ARTICLE; EARLY DIAGNOSIS; EARLY INTERVENTION; EXTRACELLULAR MATRIX; FETUS DEATH; FETUS MEMBRANE; FIRST TRIMESTER PREGNANCY; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOPHYSIOLOGY; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PREMATURITY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; PROTEOGLYCAN SYNTHESIS; EMBRYO MEMBRANE; FEMALE; GENETICS; METABOLIC SYNDROME X; METABOLISM; PLACENTA; PREGNANCY; PRENATAL CARE; RISK FACTOR;

ADAMTS9 PROTEIN; DIABETES, GESTATIONAL; EXTRAEMBRYONIC MEMBRANES; FEMALE; HUMANS; METABOLIC SYNDROME; PLACENTA; PREGNANCY; PRENATAL CARE; PROTEOGLYCANS; RISK FACTORS;

EID: 84904272615     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2014.06.020     Document Type: Article

References (14)

1. Shaat, N., Groop, L., Genetics of gestational diabetes mellitus. Curr Med Chem 14:5 (2007), 569–583.
2. Wier LM., Witt E., Burgess J., Elixhauser A. Hospitalizations related to Diabetes in Pregnancy, 2008. HCUP Statistical Brief #102.
3. Wild, S., Roglic, G., Green, A., Sicree, R., King, H., Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:5 (2004), 1047–1053.
4. Kim, C., Newton, K.M., Knopp, R.H., Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25:10 (2002), 1862–1868.
5. Bellamy, L., Casas, J.P., Hingorani, A.D., Williams, D., Type 2 diabetes after gestational diabetes a systematic review and meta-analysis. Lancet 373 (2009), 1773–1779.
6. Galis, Z.S., Khatri, J.J., Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 90 (2002), 251–262.
7. Grarup, N., Andersen, G., Krarup, N.T., Association testing of novel type 2 diabetes risk alleles in the JAZF1, CDC123/CAMK1D, TSPAN8, THADA, ADAMTS9, and NOTCH2 loci with insulin release, insulin sensitivity, and obesity in a population-based sample of 4,516 glucose-tolerant middle-aged Danes. Diabetes 57:9 (2008), 2534–2540.
8. Kirn-Safran, C., Farach-Carson, M.C., Carson, D.D., Multifunctionality of extracellular and cell surface heparan sulfate proteoglycans. Cell Mol Life Sci 66:21 (2009), 3421–3434.
9. Giachini, F.R., Carriel, V., Capelo, L.P., Maternal diabetes affects specific extracellular matrix components during placentation. J Anat 212:1 (2008), 31–41.
10. Gumus, I.I., Turhan, N.O., Are patients with positive screening but negative diagnostic test for gestational diabetes under risk for adverse pregnancy outcome?. J Obstet Gynaecol Res 34:3 (2008), 359–363.
11. Malemud, C.J., Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci 11 (2006), 1696–1701.
12. Ho, M.M., Yoganathan, P., Chu, K.Y., Karunakaran, S., Johnson, J.D., Clee, S.M., Diabetes genes identified by genome-wide association studies are regulated in mice by nutritional factors in metabolically relevant tissues and by glucose concentrations in islets. BMC Genet, 25(14), 2013 Feb, 10.
13. Chen, C.P., Chang, S.C., Vivian Yang, W.C., High glucose alters proteoglycan expression and the glycosaminoglycan composition in placentas of women with gestational diabetes mellitus and in cultured trophoblasts. Placenta 28:2–3 (2007), 97–106.
14. Chang, S.C., Vivian Yang, W.C., Hyperglycemia induces altered expressions of angiogenesis associated molecules in the trophoblast. Evid Based Complement Altern Med, 2013, 2013, 457971.